Evidence map›Paper›PMID 30894846›Full record

ArticleFrontiers in microbiology2019

Mónika Homa, Alexandra Sándor, Eszter Tóth, Csilla Szebenyi, Gábor Nagy, Csaba Vágvölgyi, Tamás Papp

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Role of Iron Availability in ModulatingJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Interactions between Bacteria andJournal of fungi (Basel, Switzerland) · 2023
    Review
  4. Journal of fungi (Basel, Switzerland) · 2023
    Article
  5. Dot Immunobinding Assay for the Rapid Serodetection ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Influence of relevant cystic fibrosis bacteria on Scedosporium apiospermum and Scedosporium boydii growth and viability.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  10. Synthesis of the Hydroxamate SiderophoreFrontiers in cellular and infection microbiology · 2020
    Article
  11. Therapeutic Challenges of Non-Antimicrobial agents and chemotherapy · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mónika HomaMTA-SZTE "Lendület" Fungal Pathogenicity Mechanisms Research Group, Szeged, Hungary.
Alexandra SándorMTA-SZTE "Lendület" Fungal Pathogenicity Mechanisms Research Group, Szeged, Hungary.
Eszter TóthMTA-SZTE "Lendület" Fungal Pathogenicity Mechanisms Research Group, Szeged, Hungary.
Csilla SzebenyiMTA-SZTE "Lendület" Fungal Pathogenicity Mechanisms Research Group, Szeged, Hungary.
Gábor NagyMTA-SZTE "Lendület" Fungal Pathogenicity Mechanisms Research Group, Szeged, Hungary.
Csaba VágvölgyiDepartment of Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.
Tamás PappMTA-SZTE "Lendület" Fungal Pathogenicity Mechanisms Research Group, Szeged, Hungary.
University of Szeged · HUMTA-SZTE Research Group on Artificial Intelligence · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the

Indexed as

cystic fibrosisdiffusible signal factorflucloxacillinPseudomonas aeruginosapyocyaninScedosporiumtobramycinvolatile organic compounds

Identifiers

PMID30894846
PMCPMC6414507
OpenAlexW2921764699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.